These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38934510)

  • 21. Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics.
    Jeswani G; Chablani L; Gupta U; Sahoo RK; Nakhate KT; Ajazuddin
    Biomed Pharmacother; 2021 Dec; 144():112286. PubMed ID: 34653755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells.
    Jin C; Bai L; Wu H; Song W; Guo G; Dou K
    Pharm Res; 2009 Jul; 26(7):1776-84. PubMed ID: 19384463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
    Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
    J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development, Optimization, and in vitro Evaluation of Silybin-loaded PLGA Nanoparticles and Decoration with 5TR1 Aptamer for Targeted Delivery to Colorectal Cancer Cells.
    Rahimnia SM; Saeedi M; Akbari J; Morteza-Semnani K; Hedayatizadeh-Omran A; Yazdian-Robati R
    AAPS PharmSciTech; 2024 Jun; 25(6):141. PubMed ID: 38898204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles.
    Nijhawan HP; Prabhakar B; Yadav KS
    Ther Deliv; 2024; 15(6):427-447. PubMed ID: 38722230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release and anti-proliferative effect of imatinib mesylate loaded sporopollenin microcapsules extracted from pollens of Betula pendula.
    Sargin I; Akyuz L; Kaya M; Tan G; Ceter T; Yildirim K; Ertosun S; Aydin GH; Topal M
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):749-756. PubMed ID: 28716746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Janus particles as a multifunctional drug delivery system for paclitaxel in efficient cancer treatment.
    Feng ZQ; Yan K; Li J; Xu X; Yuan T; Wang T; Zheng J
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():110001. PubMed ID: 31500023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S2P peptide-conjugated PLGA-Maleimide-PEG nanoparticles containing Imatinib for targeting drug delivery to atherosclerotic plaques.
    Esfandyari-Manesh M; Abdi M; Talasaz AH; Ebrahimi SM; Atyabi F; Dinarvand R
    Daru; 2020 Jun; 28(1):131-138. PubMed ID: 31919789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel and etoposide-loaded Poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery.
    Zhang M; Tang Y; Zhu Z; Zhao H; Yao J; Sun D
    J Biomater Sci Polym Ed; 2018 Nov; 29(16):1949-1963. PubMed ID: 29920151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
    Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
    Diab T; Alkafaas SS; Shalaby TI; Hessien M
    Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
    El-Sisi AE; Sokkar SS; Ibrahim HA; Hamed MF; Abu-Risha SE
    Fundam Clin Pharmacol; 2020 Aug; 34(4):458-475. PubMed ID: 32080901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
    Wahane A; Malik S; Shih KC; Gaddam RR; Chen C; Liu Y; Nieh MP; Vikram A; Bahal R
    ACS Appl Mater Interfaces; 2021 Sep; 13(38):45244-45258. PubMed ID: 34524806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death.
    Faraji Dizaji B; Hasani Azerbaijan M; Sheisi N; Goleij P; Mirmajidi T; Chogan F; Irani M; Sharafian F
    Int J Biol Macromol; 2020 Dec; 164():1461-1474. PubMed ID: 32735933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential.
    Fernandes E; Ferreira D; Peixoto A; Freitas R; Relvas-Santos M; Palmeira C; Martins G; Barros A; Santos LL; Sarmento B; Ferreira JA
    Int J Pharm; 2019 Oct; 570():118646. PubMed ID: 31465836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the pH Dependent Cytotoxicity of Paclitaxel Conjugated Gold Nanoparticles.
    Alhalili Z; Shapter J; Auliya NH; Sandersonb B
    Pharm Nanotechnol; 2017; 5(2):111-118. PubMed ID: 28440201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles.
    Mohammad Gholinia Sarpoli L; Zare-Karizi S; Heidari E; Hasanzadeh A; Bayandori M; Azedi F; Hamblin MR; Karimi M
    Pharm Dev Technol; 2022 Sep; 27(7):785-793. PubMed ID: 36043390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells.
    Wang S; Han F; Xie L; Liu Y; Yang Q; Zhao D; Zhao X
    Nanomedicine (Lond); 2022 Sep; 17(22):1627-1648. PubMed ID: 36636982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.